Modulation of arabinosylcytosine metabolism by arabinosyl-2-fluoroadenine in lymphocytes from patients with chronic lymphocytic leukemia: implications for combination therapy
about
Fludarabine in the treatment of chronic lymphocytic leukemia: a reviewPhase I-II clinical trial of oxaliplatin, fludarabine, cytarabine, and rituximab therapy in aggressive relapsed/refractory chronic lymphocytic leukemia or Richter syndrome.Biochemical modulation of aracytidine (Ara-C) effects by GTI-2040, a ribonucleotide reductase inhibitor, in K562 human leukemia cells.
P2860
Modulation of arabinosylcytosine metabolism by arabinosyl-2-fluoroadenine in lymphocytes from patients with chronic lymphocytic leukemia: implications for combination therapy
description
1989 nî lūn-bûn
@nan
1989 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Modulation of arabinosylcytosi ...... ations for combination therapy
@ast
Modulation of arabinosylcytosi ...... ations for combination therapy
@en
Modulation of arabinosylcytosi ...... ations for combination therapy
@nl
type
label
Modulation of arabinosylcytosi ...... ations for combination therapy
@ast
Modulation of arabinosylcytosi ...... ations for combination therapy
@en
Modulation of arabinosylcytosi ...... ations for combination therapy
@nl
prefLabel
Modulation of arabinosylcytosi ...... ations for combination therapy
@ast
Modulation of arabinosylcytosi ...... ations for combination therapy
@en
Modulation of arabinosylcytosi ...... ations for combination therapy
@nl
P2093
P1433
P1476
Modulation of arabinosylcytosi ...... ations for combination therapy
@en
P2093
P304
P407
P577
1989-11-01T00:00:00Z